CREDIT SUISSE AG/ - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q1 2022$57,000
-86.1%
40,145
-48.9%
0.00%
Q4 2021$411,000
-74.7%
78,525
-71.9%
0.00%
-100.0%
Q3 2021$1,627,000
-48.0%
279,279
-28.0%
0.00%
-50.0%
Q2 2021$3,128,000
-52.6%
388,020
-51.1%
0.00%
-33.3%
Q1 2021$6,597,000
-50.7%
792,971
-55.1%
0.00%
-57.1%
Q4 2020$13,381,000
-24.0%
1,765,390
+6.9%
0.01%
-36.4%
Q3 2020$17,608,000
-34.9%
1,651,844
-7.4%
0.01%
-42.1%
Q2 2020$27,041,000
+8.6%
1,783,709
-40.3%
0.02%
-9.5%
Q1 2020$24,889,000
-52.5%
2,987,870
-3.7%
0.02%
-44.7%
Q4 2019$52,453,000
-16.0%
3,103,749
-7.7%
0.04%
-28.3%
Q3 2019$62,443,000
-25.6%
3,362,589
-8.3%
0.05%
-28.4%
Q2 2019$83,929,000
+9.8%
3,668,238
+0.9%
0.07%
+5.7%
Q1 2019$76,455,000
+68.8%
3,637,261
-7.6%
0.07%
+48.9%
Q4 2018$45,288,000
-46.0%
3,938,058
+7.8%
0.05%
-37.3%
Q3 2018$83,856,000
+8.0%
3,653,892
+5.0%
0.08%
-1.3%
Q2 2018$77,617,000
-12.4%
3,480,603
-10.3%
0.08%
-8.4%
Q1 2018$88,640,000
+58.0%
3,879,208
+81.2%
0.08%
+66.0%
Q4 2017$56,105,000
+37.2%
2,141,432
+17.6%
0.05%
+25.0%
Q3 2017$40,894,000
+69.3%
1,821,503
+106.2%
0.04%
+66.7%
Q2 2017$24,155,000
+141.6%
883,173
+113.8%
0.02%
+166.7%
Q1 2017$9,998,000
+178.0%
413,131
+138.4%
0.01%
+125.0%
Q4 2016$3,596,000
+14.6%
173,328
+50.5%
0.00%
+33.3%
Q3 2016$3,139,000
+236.4%
115,166
+77.8%
0.00%
+200.0%
Q2 2016$933,000
+293.7%
64,771
+292.1%
0.00%
Q1 2016$237,000
-55.1%
16,518
-32.8%
0.00%
-100.0%
Q4 2015$528,000
-43.5%
24,563
-57.5%
0.00%0.0%
Q3 2015$935,000
+57.9%
57,781
+151.5%
0.00%0.0%
Q2 2015$592,000
+28.4%
22,975
+12.0%
0.00%
Q1 2015$461,000
-21.1%
20,510
-32.6%
0.00%
-100.0%
Q4 2014$584,000
-5.0%
30,425
+6.2%
0.00%0.0%
Q3 2014$615,000
-64.3%
28,656
-56.8%
0.00%0.0%
Q2 2014$1,723,000
+365.7%
66,265
+290.6%
0.00%
Q1 2014$370,000
+63.0%
16,964
-8.8%
0.00%
Q4 2013$227,000
+26.1%
18,600
+38.6%
0.00%
Q3 2013$180,00013,4240.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders